Thanks to robust research efforts, treatment options are expanding and patients are getting their diagnosis earlier – often, when they are...
West Nile Virus is the leading cause of mosquito-borne disease in the continental United States.
The results confirm in a “real-life setting” the efficacy and safety of the treatment.
Rozanolixizumab is the first FDA-approved treatment for adults with both subtypes.
One expert interviewed for this article said the study “falls short of being a credible 1/2a clinical trial.”
“The totality of clinical data suggests that Elfabrio has the potential to be a long-lasting therapy.”
These new estimates are “significantly higher” than those from a prior U.S. analysis from 2003.
“The FDA’s approval of Qalsody gives me hope that people living with this rare form of ALS could experience a reduction in decline in strength,...
The epidermis overlying cNF is normal, “so there is no reason to use nonselective or surgical methods and destroy a perfectly good epidermis when...
The drug is designed to treat the core symptoms of Rett syndrome by potentially reducing neuroinflammation and supporting synaptic function.
Observed GBS cases after the Janssen shot were 2 to 3 times greater than expected, based on background rates within 21 and 42 days of vaccination...